drugset
Drugs / Trivalent Oral Polio Vaccine (tOPV)
last change May 2016 re-read 3 minutes ago

Trivalent Oral Polio Vaccine (tOPV)

Vaccine

Developed for
poliomyelitis
Investigated by
Bill and Melinda Gates Foundation · Centers for Disease Control and Prevention · Fidec Corporation

Trials 1

today NCT01831050 · Ph 4
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01831050 May 2013 → Apr 2014 poliomyelitis Fidec Corporation Completed Met primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Trivalent Oral Polio Vaccine (tOPV) ClinicalTrials.gov intervention name — accepted as the source's own label NCT01831050 ↗
Modality Vaccine “trivalent OPV vaccine contains types 1, 2, and 3 polioviruses” NCT01831050 ↗
Route Oral “trivalent oral poliovirus vaccine (tOPV)” PMID 27212429 ↗ May 2016